Targeting ESR1 mutation-induced transcriptional addiction in breast cancer with BET inhibition.
Udden SN, Wang Q, Kumar S, Malladi VS, Wu SY, Wei S, Posner BA, Geboers S, Williams NS, Liu Y, Sharma JK, Mani RS, Malladi S, Parra K, Hofstad M, Raj GV, Larios JM, Jagsi R, Wicha MS, Park BH, Gupta GP, Chinnaiyan AM, Chiang CM, Alluri PG.
Udden SN, et al. Among authors: wang q.
JCI Insight. 2022 Sep 8;7(17):e151851. doi: 10.1172/jci.insight.151851.
JCI Insight. 2022.
PMID: 35881485
Free PMC article.